CoChat

Modular Synthesis of Semiconducting Graft Copolymers to Achieve “Clickable” Fluorescent Nanoparticles with Long Circulation and Specific Cancer Targeting

Creamer, Adam, Fiego, Alessandra Lo, Agliano, Alice, Prados‐Martin, Lino, Høgset, Håkon, Najer, Adrian, Richards, Daniel A., Wojciechowski, Jonathan P., Foote, James E. J., Kim, Nayoung, Monahan, Amy, Tang, Jiaqing, Shamsabadi, André, Rochet, Léa N. C., Thanasi, Ioanna A., de la Ballina, Laura R., Rapley, Charlotte L., Turnock, Stephen, Love, Elizabeth A., Bugeon, Laurence, Dallman, Margaret J., Heeney, Martin, Kramer‐Marek, Gabriela, Chudasama, Vijay, Fenaroli, Federico, Stevens, Molly M. · 2024 · Advanced Materials
Cited by 27

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Semiconducting polymer nanoparticles (SPNs) are explored for applications in cancer theranostics because of their high absorption coefficients, photostability, and biocompatibility. However, SPNs are susceptible to aggregation and protein fouling in physiological conditions, which can be detrimental for in vivo applications. Here, a method for achieving colloidally stable and low‐fouling SPNs is described by grafting poly(ethylene glycol) (PEG) onto the backbone of the fluorescent semiconducting polymer, poly(9,9′‐dioctylfluorene‐5‐fluoro‐2,1,3‐benzothiadiazole), in a simple one‐step substitution reaction, postpolymerization. Further, by utilizing azide‐functionalized PEG, anti‐human epidermal growth factor receptor 2 (HER2) antibodies, antibody fragments, or affibodies are site‐specifically “clicked” onto the SPN surface, which allows the functionalized SPNs to specifically target HER2‐positive cancer cells. In vivo, the PEGylated SPNs are found to have excellent circulation efficiencies in zebrafish embryos for up to seven days postinjection. SPNs functionalized with affibodies are then shown to be able to target HER2 expressing cancer cells in a zebrafish xenograft model. The covalent PEGylated SPN system described herein shows great potential for cancer theranostics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/adma.202300413

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 58

  1. 10.1016/j.biomaterials.2017.11.025 · DOI · Paper page
  2. 10.1021/acs.accounts.9b00569 · DOI · Paper page
  3. 10.1039/D0MH00012D · DOI
  4. 10.1002/anie.201814730 · DOI · Paper page
  5. 10.1021/jacs.8b13507 · DOI · Paper page
  6. 10.1002/ange.201808074 · DOI
  7. 10.7150/thno.34390 · DOI · Paper page
  8. 10.1039/D0SC01721C · DOI
  9. 10.1002/adfm.201605397 · DOI · Paper page
  10. 10.1002/adma.201801331 · DOI · Paper page
  11. 10.1080/17425247.2021.1874916 · DOI
  12. 10.1002/adma.202110305 · DOI
  13. 10.1021/acsanm.9b02292 · DOI
  14. 10.1021/ja107196s · DOI · Paper page
  15. 10.1016/0300-483X(95)03123-W · DOI · Paper page
  16. 10.1080/14686996.2017.1370361 · DOI
  17. 10.1039/C6SC02403C · DOI · Paper page
  18. 10.1016/j.jconrel.2020.01.035 · DOI · Paper page
  19. 10.1158/1078-0432.CCR-03-0041 · DOI
  20. 10.2147/IJN.S153795 · DOI
  21. 10.1042/BJ20101860 · DOI · Paper page
  22. 10.1016/j.jbiotec.2009.01.014 · DOI
  23. 10.1016/j.ddtec.2018.10.005 · DOI · Paper page
  24. 10.1007/s00259-007-0658-0 · DOI · Paper page
  25. 10.1038/s41419-020-03077-6 · DOI
  26. 10.1016/j.biomaterials.2010.11.053 · DOI
  27. 10.1002/smll.201002291 · DOI · Paper page
  28. Narsireddy A., 2015, Int. J. Nanomed., 10, 6865
  29. 10.1002/smll.201602807 · DOI · Paper page
  30. 10.1039/c3py00605k · DOI
  31. 10.1002/smll.201906719 · DOI
  32. 10.1016/j.ebiom.2020.102902 · DOI
  33. 10.1021/acsapm.2c01153 · DOI
  34. 10.1021/acs.analchem.9b03010 · DOI
  35. 10.1021/acsami.5b04987 · DOI
  36. 10.1039/C6RA18678E · DOI
  37. 10.1038/s41598-022-15244-0 · DOI
  38. 10.1002/mabi.202000087 · DOI
  39. 10.1038/s41467-018-05381-4 · DOI
  40. 10.1007/s10118-021-2537-8 · DOI
  41. 10.1039/D2MH00519K · DOI
  42. 10.1002/ppsc.201400123 · DOI · Paper page
  43. 10.1039/C5TB01827G · DOI
  44. 10.1002/adhm.201300534 · DOI
  45. 10.1002/adma.201502285 · DOI · Paper page
  46. 10.1002/smll.202004723 · DOI · Paper page
  47. 10.1039/C8SC00206A · DOI · Paper page
  48. 10.1002/ange.201303420 · DOI
  49. 10.1002/smll.201907574 · DOI · Paper page
  50. 10.1021/acscentsci.1c01368 · DOI
  51. 10.1002/smll.202201993 · DOI
  52. 10.1039/D0OB00106F · DOI
  53. 10.1039/D2OB00310D · doi:10.1039/d2ob00310d
  54. 10.1021/acsnano.7b06995 · DOI · Paper page
  55. 10.1002/adma.201906274 · DOI
  56. 10.1021/nn506750r · DOI
  57. 10.1093/bioinformatics/btu328 · DOI
  58. Kapusta P., 2010, Absolute Diffusion Coefficients: Compilation of Reference Data for FCS Calibration

Cited by

See all 27

Metadata

Authors
Creamer, A., Fiego, A. L., Agliano, A., Prados‐Martin, L., Høgset, H., Najer, A., Richards, D. A., Wojciechowski, J. P., Foote, J. E. J., Kim, N., Monahan, A., Tang, J., Shamsabadi, A., Rochet, L. N. C., Thanasi, I. A., de la Ballina, L. R., Rapley, C. L., Turnock, S., Love, E. A., Bugeon, L., Dallman, M. J., Heeney, M., Kramer‐Marek, G., Chudasama, V., Fenaroli, F., & Stevens, M. M.
Venue
Advanced Materials
Publisher
Wiley
Published
2023-04-02
Volume
36
Issue
20
ISSN
  • 0935-9648
  • 1521-4095
Cited by
27
References
3
Language
en
Funders
  • Cancer Research UK (100063, 27886, 29385)
  • Leverhulme Trust
  • Engineering and Physical Sciences Research Council (EP/S023518/1, EP/K020641/1, EP/T517793/1)
  • Wellcome Trust (209121_Z_17_Z)
  • UK Regenerative Medicine Platform (MR/R015651/1)
  • Rosetrees Trust
  • European Commission (859458)
  • LifeArc
  • Institute of Cancer Research
  • Royal Society
  • Wolfson Foundation
  • Kreftforeningen (711091)
  • H2020 Excellent Science (859458)
  • University College London

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.